BridgeBio Oncology Therapeutics, Inc. - Common Stock (BBOT)

Last Price10.03

Change-0.22 (-2.15%)

NASDAQ · Last Trade: Feb 28th, 6:31 AM EST

Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million?

Via The Motley Fool · December 22, 2025